The Role of 5-Hydroxymethylcytosine in Aging and Alzheimer's Disease: Current Status and Prospects for Future Studies

Daniel L. A. van den Hove*, Leonidas Chouliaras, Bart P. F. Rutten

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

48 Citations (Web of Science)


Epigenetic modifications have been proposed to underlie age-related dysfunction and associated disorders. 5- hydroxymethylcytosine (5-hmC) is a newly described epigenetic modification. It is generated by the oxidation of 5- methylcytosine (5-mC) by the ten-eleven translocation (TET) family of enzymes. Various studies have shown that 5-hmC is present in high levels in the brain. Its lower affinity to methyl-binding proteins as compared to 5-mC suggests that it might have a different role in the regulation of gene expression, while it is also implicated in the DNA demethylation process. Interestingly, various widely used methods for DNA methylation detection fail to discriminate between 5-hmC and 5-mC, while numerous specific techniques are currently being developed. Recent studies have indicated an increase of 5-hmC with age in the mouse brain as well as an age- and gene-expression-level-related enrichment of 5-hmC in genes implicated in neurodegeneration. These findings suggest that 5-hmC may play an important role in the etiology and course of age-related neurodegenerative disorders. The present perspective summarizes the current knowledge on 5-hmC, discusses methodological challenges related to its detection, and suggests future strategies for examining the functional role of this epigenetic modification and its possible implication in aging and Alzheimer's disease.
Original languageEnglish
Pages (from-to)545-549
JournalCurrent Alzheimer Research
Issue number5
Publication statusPublished - Jun 2012


  • Aging
  • Alzheimer's disease
  • epigenesis
  • epigenetics
  • 5-hydroxymethylcytosine
  • DNA
  • hydroxymethylation

Cite this